MedicinMan | Amplifying Healthcare Voices

Tuesday, April 14, 2026

35 C

Bengaluru

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Exclusive Articles Anup Soans - April 10, 2026

Sun Pharma’s Odyssey and Organon’s Second Act – And Why the Attempted Union (Even...

Special Issue

Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie

Exclusive Articles

Strategic Communications for Healthcare Brands

Featured Article

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...

Exclusive Report

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

"Those who cannot remember the past are condemned to...

Special Issue

Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie

A Tale of Two Truths: Severance, Up in the...

Exclusive Report

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

AI in Healthcare

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Biologics

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Exclusive Articles

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

From Gas Cylinders to ICU Beds: How the Gulf...

Exclusive Articles

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

In the blistering Sonoran Desert, where temperatures regularly exceed...

Topics

Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.

Healthcare C-Suite Movements April 4, 2026

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

Exclusive Articles April 3, 2026

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

Exclusive Report April 2, 2026

IPM February 2026: Market Intelligence Report

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

AI in Healthcare March 31, 2026

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Biologics March 25, 2026

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

Exclusive Articles March 23, 2026

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

Excellence or Mediocrity—What Are You Building?

Leaderspeak March 19, 2026

Don't Miss MedicinMan Updates

Hot this week

AI in Healthcare

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

March 3, 2025 0

1. Market Overview The oncology sector remains the most dominant...

AI in Healthcare

Blinkit, Zepto, Instamart: Who Will Own India’s At‑Home Diagnostics Market?

November 30, 2025 0

India’s diagnostics market is undergoing a quiet but profound...

Popular Categories

Featured Article89 Healthcare News51 Exclusive Articles49 Leaderspeak47 Special Issue46 Thought Leadership20

Video Insights

The Hidden Crisis in Pharma: Why Face-to-Face Reps Are No Longer Enough

39:26

MedicinMan CEO Insights - Leading with Empathy: Mankind's Success Story.

02:30

MedicinMan CEO Insights - The Rise of Digital Apps in Healthcare

00:49

MedicinMan CEO Insights - Transforming Healthcare: Technology in Fertility and Pharma #medicinman

02:52

MedicinMan CEO Insights - How Tech is Revolutionizing Doctor-Patient Engagement. #medicinman

02:43

Head Start - Six Key Skills for Your Career's Success #keytakeaways #medicinman #anupsoans

02:25

Headlines

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

Exclusive Articles Anup Soans - March 16, 2026

In the blistering Sonoran Desert, where temperatures regularly exceed 100 degrees Fahrenheit, a sluggish, beaded lizard emerges from its...

The Uncomfortable Truth about Indian Generics: Untangling the Conundrum

Exclusive Articles Anup Soans - February 3, 2026

India’s pharmaceutical industry occupies a unique and powerful position in global healthcare. It supplies nearly half of all generic...

Exclusive Articles

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

April 10, 2026

Sun Pharma’s Odyssey and Organon’s Second Act – And Why the Attempted Union (Even If It Never Closes) Reveals...

Digital Noise to Digital Voice – A 4-Module Workshop for Pharma People

Special Announcement Anup Soans - October 14, 2021

National Seminar on UCPMP

Special Announcement Anup Soans - August 20, 2016

Music

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

Brecht Vanneste has been appointed as Managing Director of MSD India

Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.

Sachhin Misshra has been elevated to the role of...

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

Food

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

Brecht Vanneste has been appointed as Managing Director of MSD India

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Samuel Paradise

Exclusive Articles

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Featured Article

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

Exclusive Report

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

Healthcare C-Suite Movements

Brecht Vanneste has been appointed as Managing Director of MSD India

Featured Article

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Manuela Cole

Exclusive Articles

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Featured Article

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

Exclusive Report

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

Healthcare C-Suite Movements

Brecht Vanneste has been appointed as Managing Director of MSD India

Featured Article

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Keisha Adams

Exclusive Articles

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Featured Article

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

Exclusive Report

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

Healthcare C-Suite Movements

Brecht Vanneste has been appointed as Managing Director of MSD India

Featured Article

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

George Pharell

Exclusive Articles

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Featured Article

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

Exclusive Report

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

Healthcare C-Suite Movements

Brecht Vanneste has been appointed as Managing Director of MSD India

Featured Article

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Leaders Speak

Business leaders sharing their insights

Salil Kallianpur

14 POSTS

http://salilkallianpur.wordpress.com

8 POSTS

6 POSTS

6 POSTS

5 POSTS

5 POSTS

3 POSTS

https://www.enparadigm.com/

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

.st0{fill:#FFFFFF;} .st1{fill:#E52E2E;}

Hot topics

Healthcare Trends

Marketing

Policies/Sales

Strategy

Hot topics

Healthcare Trends

Marketing

Policies/Sales

Strategy

Topics

Follow Us

Video Insights

Headlines

Music

Food

Leaders Speak

Business leaders sharing their insights

Company

Headlines

Newsletter